a nonsignificant trendP= 0.36
A nonsignificant trend towards longer survival was observed in those with low UBC9 levels ( P= 0.36), those with low BRCA1 levels ( P= 0.36) and those with low MDC1 levels ( P= 0.67).
A nonsignificant trend towards longer survival was observed in those with low UBC9 levels ( P= 0.36), those with low BRCA1 levels ( P= 0.36) and those with low MDC1 levels ( P= 0.67).